Title: EVALUATING CLINICAL UTILITY OF A UIP GENOMIC CLASSIFIER IN SUBJECTS WITH AND WITHOUT A HRCT PATTERN OF UIP
Abstract: SESSION TITLE: Diagnosis and Treatment of IPF SESSION TYPE: Original Investigations PRESENTED ON: 10/20/2019 2:15 PM - 3:15 PM PURPOSE: Diagnostic evaluation for idiopathic pulmonary fibrosis (IPF) includes radiology and multi-disciplinary review (MDD). The Envisia Genomic Classifier (EGC), a 190-gene machine learning classifier using transbronchial biopsies, provides a binary prediction of UIP or non-UIP. The EGC shows sensitivity of 70% and specificity of 88% against a histopathology reference standard. We evaluated the utility and confidence of IPF diagnosis informed by EGC results. METHODS: BRAVE is a multicenter observational study of patients with suspected interstitial lung disease. 94 BRAVE subjects with HRCT scans, central radiology review, central histopathology diagnoses, and EGC results were evaluated. Two blinded MDDs including an ILD pulmonologist, radiologist, and pathologist were convened. Two subject files were prepared with patient history and central radiology results. One version included histopathology images (pathology-MDD) and central histopathology evaluations while the other version included the EGC result (EGC-MDD). Subject versions were randomly assigned to MDDs. Each MDD independently determined a categorical clinical diagnosis of IPF versus non-IPF, with associated confidence. Clinical diagnoses were compared within radiology UIP categories. RESULTS: IPF diagnoses by EGC-MDD and pathology-MDD were concordant (>86% agreement). Central radiology diagnosed 27% (25/94) of patients with HRCT-UIP (definite, probable or possible UIP) and 73% (69/94) as inconsistent with UIP. 17 of 25 with HRCT-UIP (68%) were diagnosed with IPF by both EGC-MDD and pathology-MDD. 94% of EGC-MDD IPF diagnoses were confident, compared to 53% with histopathology (p=0.008). For 69 subjects with radiology inconsistent with UIP, EGC-MDD and histopathology-MDD agreement is 90%, with 61 diagnosed with non-IPF and 1 diagnosed with IPF in both. CONCLUSIONS: EGC results support confident IPF diagnoses in subjects with HRCT-UIP. When radiology is inconsistent with UIP, EGC-MDD diagnoses are concordant with histopathology-MDD diagnoses of IPF vs. non-IPF. CLINICAL IMPLICATIONS: The Envisia Genomic Classifier enhances diagnostic confidence in IPF, with high concordance to multidisciplinary diagnoses informed by pathology. DISCLOSURES: no disclosure on file for Neil Barth; No relevant relationships by Sadia Benzaquen, source=Web Response Advisory Committee Member relationship with Boehringer Ingelheim Please note: $20001 - $100000 Added 03/16/2019 by Kevin Brown, source=Web Response, value=Consulting fee Consultant relationship with Veracyte Please note: $1001 - $5000 Added 03/16/2019 by Kevin Brown, source=Web Response, value=Consulting fee Advisory Committee Member relationship with Galecto Please note: $1001 - $5000 Added 03/16/2019 by Kevin Brown, source=Web Response, value=Consulting fee Advisory relationship with Biogen Please note: $5001 - $20000 Added 03/16/2019 by Kevin Brown, source=Web Response, value=Consulting Advisory Committee Member relationship with Galapagos Please note: $1001 - $5000 Added 03/16/2019 by Kevin Brown, source=Web Response, value=Consulting fee Advisory Committee Member relationship with monARC Bionetworks Please note: $1-$1000 Added 03/16/2019 by Kevin Brown, source=Web Response, value=Consulting fee Advisory Committee Member relationship with Pliant Please note: $1-$1000 Added 03/16/2019 by Kevin Brown, source=Web Response, value=Consulting fee Advisory Committee Member relationship with Lifemax Please note: $1-$1000 Added 03/16/2019 by Kevin Brown, source=Web Response, value=Consulting fee Consultant relationship with Theravance Please note: $1001 - $5000 Added 03/16/2019 by Kevin Brown, source=Web Response, value=Consulting fee Advisory Committee Member relationship with Prometic Please note: $1001 - $5000 Added 03/16/2019 by Kevin Brown, source=Web Response, value=Consulting fee Advisory Committee Member relationship with ThirdPole Please note: $1001 - $5000 Added 03/16/2019 by Kevin Brown, source=Web Response, value=Consulting fee Research support grant relationship with Veracyte Please note: $5001 - $20000 Added 03/16/2019 by Karel Calero, source=Web Response, value=Grant/Research Support Speaker/Speaker's Bureau relationship with Boehringer Ingelheim Please note: $1001 - $5000 Added 11/15/2018 by Amy Case, source=Web Response, value=Honoraria Advisory Committee Member relationship with Genentech Please note: $1001 - $5000 Added 11/15/2018 by Amy Case, source=Web Response, value=Honoraria Speaker/Speaker's Bureau relationship with Genentech Please note: $5001 - $20000 Added 11/15/2018 by Amy Case, source=Web Response, value=Honoraria Employee relationship with Veracyte Inc Please note: >$100000 Added 03/21/2019 by Yoonha Choi, source=Web Response, value=Salary Removed 03/21/2019 by Yoonha Choi, source=Web Response Employee relationship with Veracyte Inc Please note: >$100000 Added 03/21/2019 by Yoonha Choi, source=Web Response, value=Salary Speaker/Speaker's Bureau relationship with Boehringer Ingelheim Please note: $20001 - $100000 Added 03/15/2019 by Jonathan Chung, source=Web Response, value=Honoraria Speaker/Speaker's Bureau relationship with Genentech Please note: $20001 - $100000 Added 03/15/2019 by Jonathan Chung, source=Web Response, value=Honoraria Consultant relationship with Veracyte Please note: $5001 - $20000 Added 03/15/2019 by Jonathan Chung, source=Web Response, value=Honoraria<br No relevant relationships by Thomas Colby, source=Web Response Advisory Committee Member relationship with Boehringer Ingelheim Please note: $1001 - $5000 Added 03/12/2019 by Gerard Criner, source=Web Response, value=Honoraria Advisory Committee Member relationship with GSK Please note: $1001 - $5000 Added 03/13/2019 by Gerard Criner, source=Web Response, value=Consulting fee Consultant relationship with pulmonx Please note: $1-$1000 Added 05/30/2019 by Gerard Criner, source=Web Response, value=Consulting fee Consultant relationship with olympus Please note: $1001 - $5000 Added 05/30/2019 by Gerard Criner, source=Web Response, value=Consulting fee Consultant relationship with astra zeneca Please note: $1001 - $5000 Added 05/30/2019 by Gerard Criner, source=Web Response, value=Consulting fee Advisory Committee Member relationship with gala Please note: $1001 - $5000 Added 05/30/2019 by Gerard Criner, source=Web Response, value=Consulting fee Consultant relationship with CSA medical Please note: $1001 - $5000 Added 05/30/2019 by Gerard Criner, source=Web Response, value=Grant/Research Support Advisory Committee Member relationship with respironics Please note: $1001 - $5000 Added 05/30/2019 by Gerard Criner, source=Web Response, value=Consulting fee Advisory Committee Member relationship with rested Please note: $1001 - $5000 Added 05/30/2019 by Gerard Criner, source=Web Response, value=Grant/Research Support No relevant relationships by John Davis, source=Web Response Consultant relationship with Veracyte Please note: $1001 - $5000 Added 03/18/2019 by Kevin Flaherty, source=Web Response, value=Consulting fee Consultant relationship with Boehringer Ingelheim Please note: $20001 - $100000 Added 03/18/2019 by Kevin Flaherty, source=Web Response, value=Consulting fee Consultant relationship with Roche/Genentech Please note: $5001 - $20000 Added 03/18/2019 by Kevin Flaherty, source=Web Response, value=Consulting fee Consultant relationship with Bellapheron Please note: $1001 - $5000 Added 03/18/2019 by Kevin Flaherty, source=Web Response, value=Consulting fee No relevant relationships by Umair Gauhar, source=Web Response Consultant relationship with Veracyte Please note: $5001 - $20000 Added 03/22/2019 by Steve Groshong, source=Web Response, value=Consulting fee no disclosure on file for Lars Hagmeyer; Employee relationship with Veracyte Inc Please note: >$100000 Added 03/15/2019 by Jing Huang, source=Web Response, value=Salary no disclosure on file for Giulia Kennedy; Slide review relationship with Veracyte Please note: $5001 - $20000 Added 03/15/2019 by Brandon Larsen, source=Web Response, value=Slide review fee Removed 03/15/2019 by Brandon Larsen, source=Web Response Consultant relationship with Veracyte Please note: $5001 - $20000 Added 03/15/2019 by Brandon Larsen, source=Web Response, value=Consulting fee Consultant relationship with Veracyte Please note: $5001 - $20000 Added 03/18/2019 by David Lederer, source=Web Response, value=Consulting fee Consultant relationship with Roche Please note: $1-$1000 Added 03/18/2019 by David Lederer, source=Web Response, value=Consulting fee Advisory Committee Member relationship with Boehringer-Ingelheim Please note: $1-$1000 Added 03/18/2019 by David Lederer, source=Web Response, value=0 Consultant relationship with Galapagos Please note: $1-$1000 Added 03/18/2019 by David Lederer, source=Web Response, value=Consulting fee Advisory Committee Member relationship with Fibrogen Please note: $1-$1000 Added 03/18/2019 by David Lederer, source=Web Response, value=Consulting fee Advisory Committee Member relationship with Global Blood Therapeutics Please note: $1001 - $5000 Added 03/18/2019 by David Lederer, source=Web Response, value=Consulting fee Consultant relationship with Galecto Please note: $1-$1000 Added 03/18/2019 by David Lederer, source=Web Response, value=Travel Advisory Committee Member relationship with Sanofi Genzyme Please note: $5001 - $20000 Added 03/18/2019 by David Lederer, source=Web Response, value=Consulting fee Employee relationship with Veracyte Please note: >$100000 Added 03/15/2019 by Lori Lofaro, source=Web Response, value=Salary Consultant relationship with Parexel Inc Please note: $1001 - $5000 Added 03/28/2019 by David Lynch, source=Web Response, value=Consulting fee Consultant relationship with Siemens Please note: $5001 - $20000 Added 03/28/2019 by David Lynch, source=Web Response, value=Consulting fee Consultant relationship with Boehringer Ingelheim Please note: $1001 - $5000 Added 03/28/2019 by David Lynch, source=Web Response, value=Consulting fee Speaker/Speaker's Bureau relationship with France Foundation Please note: $5001 - $20000 Added 03/28/2019 by David Lynch, source=Web Response, value=Honoraria Consultant relationship with AstraZeneca Please note: $5001 - $20000 Added 03/14/2019 by Fernando Martinez, source=Web Response, value=Consulting fee Consultant relationship with GlaxoSmithKline Please note: $20001 - $100000 Added 03/14/2019 by Fernando Martinez, source=Web Response, value=Consulting fee Consultant relationship with Boehringer Ingelheim Please note: $5001 - $20000 Added 03/14/2019 by Fernando Martinez, source=Web Response, value=Consulting fee Consultant relationship with Chiesi Please note: $5001 - $20000 Added 03/14/2019 by Fernando Martinez, source=Web Response, value=Travel Consultant relationship with Sunovion Please note: $1001 - $5000 Added 03/14/2019 by Fernando Martinez, source=Web Response, value=Consulting fee Consultant relationship with teva Please note: $5001 - $20000 Added 03/14/2019 by Fernando Martinez, source=Web Response, value=Consulting fee no disclosure on file for Jeffrey Myers; Consultant relationship with Roche-Genentech Please note: $20001 - $100000 Added 03/15/2019 by Steven Nathan, source=Web Response, value=Consulting fee Speaker/Speaker's Bureau relationship with Boerhinger-Ingelheim Please note: $20001 - $100000 Added 03/15/2019 by Steven Nathan, source=Web Response, value=Honoraria Consultant relationship with Promedior Please note: $5001 - $20000 Added 03/15/2019 by Steven Nathan, source=Web Response, value=Consulting fee Consultant relationship with Bellerophon Please note: $5001 - $20000 Added 03/15/2019 by Steven Nathan, source=Web Response, value=Consulting fee Advisory Committee Member relationship with United Therapeutics Please note: $1001 - $5000 Added 03/15/2019 by Steven Nathan, source=Web Response, value=Consulting fee Employee relationship with Veracyte, Inc Please note: $20001 - $100000 Added 03/16/2019 by Hannah Neville, source=Web Response, value=Salary Employee relationship with Veracyte Please note: >$100000 Added 03/18/2019 by Daniel Pankratz, source=Web Response, value=Salary no disclosure on file for Ganesh Raghu; No relevant relationships by Navdeep Rai, source=Web Response no disclosure on file for Murali Ramaswamy; no disclosure on file for Mark Steele; Employee relationship with Veracyte Please note: >$100000 Added 03/18/2019 by Patric Walsh, source=Web Response, value=Salary